about
Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: A systematic review.Development of a web-based application and multicountry analysis framework for assessing interdicted infections and cost-utility of screening donated blood for HIV, HCV and HBV.Impact and cost-effectiveness of rotavirus vaccination in BangladeshStrategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis.A systematic review of health economic evaluations of vaccines in Brazil.Economic analysis of costs with enteral and parenteral nutritional therapy according to disease and outcome.Adapting Pharmacoeconomics to Shape Efficient Health Systems en Route to UHC - Lessons from Two Continents.Revealed willingness-to-pay versus standard cost-effectiveness thresholds: Evidence from the South African HIV Investment Case.Cost-effectiveness of maternal GBS immunization in low-income sub-Saharan Africa.Economic evaluation of HCV testing approaches in low and middle income countries.Comment on: “Forecasting Pharmaceutical Prices for Economic Evaluations When There is No Market: A Review”.Calculation of the disease burden associated with environmental chemical exposures: application of toxicological information in health economic estimation.Economic evaluations of HBV testing and treatment strategies and applicability to low and middle-income countries.Progressive realisation of universal health coverage: what are the required processes and evidence?Global economic evaluation of oral cholera vaccine: A systematic review.Cost-Effectiveness of Nivolumab in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma.Value-Based Pricing: L'Enfant Terrible?Analysis of the cost-effectiveness of carbetocin for the prevention of hemorrhage following cesarean delivery in Ecuador.Voluntary Community Human Immunodeficiency Virus Testing, Linkage, and Retention in Care Interventions in Kenya: Modeling the Clinical Impact and Cost-effectiveness.Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays?Cost effectiveness of mHealth intervention by community health workers for reducing maternal and newborn mortality in rural Uttar Pradesh, India.Primary and secondary prevention interventions for cardiovascular disease in low-income and middle-income countries: a systematic review of economic evaluations.Comparative cost-effectiveness of surgery, angioplasty, or medical therapy in patients with multivessel coronary artery disease: MASS II trialEconomic Evaluation of Letrozole for Early Breast Cancer in a Health Resource-Limited SettingIncorporating MCDA into HTA: challenges and potential solutions, with a focus on lower income settings
P2860
Q30235262-42187143-E12B-42DF-A246-582065F6FFACQ30491951-8BB3CE45-FE20-4E65-9E05-0E398FD37B12Q33907724-B4254083-55DD-48BC-A8A3-F3D79E870B02Q38631865-064A11DA-DCD8-456A-AA58-A3CCF111B16CQ38995392-64B24AEC-0DD6-4F21-AD1E-5DB73C2C2CFEQ40109848-085A95F7-60B4-4D25-965B-2F5B9E1BD858Q42700388-209079A4-691A-4FDB-B0D5-B915F6C7AB97Q44032580-6ED7CF74-77C1-4062-B18E-5BEF7CC57495Q46543437-54C4822A-98F2-4575-BB42-116EBD614702Q46983780-D78E753C-7A66-4335-9FD6-659B0177AAA9Q47094481-DBCA8130-AB06-4945-8135-8C87B8925D4DQ47096835-4FFDAD56-DA12-4D35-BABB-71F259988A65Q47103647-80FE2774-FB4E-4FB2-89CD-399DBD0536F5Q47138800-E53EB131-934E-4E28-B270-2F7E02FF5539Q47628812-9273DE82-0E88-4DF8-8F67-B630E1394BF5Q47665473-8B9587F9-4072-400A-8DC3-89BD73D2B2BAQ49756124-6806CBC8-A79C-4422-8677-92F5E3CC438BQ50200888-189DA70A-7C35-4E3E-BAD6-1E5E47ABDC26Q54215604-917EF7AF-7D95-41C3-927E-FEE8DE998A60Q55085155-2A77B308-8273-4913-AD31-F243F626DACFQ55438034-F763A40A-A365-4853-97D7-90DBA5BCEEF8Q55483901-BABFA042-2F45-47DF-BBEA-E30DABEF2B17Q58613912-0F359D92-CDB8-4D10-A6E5-7C7518E8C90BQ58803015-2702C28A-4BA0-4060-96AF-B0BBF2FF764BQ59137037-028949CC-6C3D-49E6-8923-2DCBBE9EBB48
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cost-effectiveness thresholds: pros and cons.
@en
Cost-effectiveness thresholds: pros and cons.
@nl
type
label
Cost-effectiveness thresholds: pros and cons.
@en
Cost-effectiveness thresholds: pros and cons.
@nl
prefLabel
Cost-effectiveness thresholds: pros and cons.
@en
Cost-effectiveness thresholds: pros and cons.
@nl
P2093
P2860
P356
P1476
Cost-effectiveness thresholds: pros and cons.
@en
P2093
Jeremy A Lauer
Kees De Joncheere
Marie-Paule Kieny
Melanie Y Bertram
Raymond Hutubessy
Suzanne R Hill
Tessa Edejer
P2860
P304
P356
10.2471/BLT.15.164418
P407
P577
2016-09-19T00:00:00Z